Canada · Delayed Price · Currency is CAD TelyRx Holdings Statistics
Total Valuation
TelyRx Holdings has a market cap or net worth of CAD 111.87 million. The enterprise value is 118.89 million.
| Market Cap | 111.87M |
| Enterprise Value | 118.89M |
Important Dates
The next estimated earnings date is Tuesday, November 10, 2026.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TelyRx Holdings has 48.85 million shares outstanding. The number of shares has increased by 187.93% in one year.
| Current Share Class | 26.35M |
| Shares Outstanding | 48.85M |
| Shares Change (YoY) | +187.93% |
| Shares Change (QoQ) | -3.49% |
| Owned by Insiders (%) | 38.43% |
| Owned by Institutions (%) | n/a |
| Float | 11.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.85 |
| PS Ratio | 0.99 |
| PB Ratio | 8.63 |
| P/TBV Ratio | 10.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 1.47.
| Current Ratio | 1.91 |
| Quick Ratio | 1.29 |
| Debt / Equity | 1.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.91 |
Financial Efficiency
Return on equity (ROE) is -802.88% and return on invested capital (ROIC) is -63.99%.
| Return on Equity (ROE) | -802.88% |
| Return on Assets (ROA) | -47.02% |
| Return on Invested Capital (ROIC) | -63.99% |
| Return on Capital Employed (ROCE) | -65.26% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 4.31 |
| Inventory Turnover | 22.90 |
Taxes
In the past 12 months, TelyRx Holdings has paid 53,947 in taxes.
| Income Tax | 53,947 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.67% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -23.67% |
| 50-Day Moving Average | 2.42 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.98 |
| Average Volume (20 Days) | 8,380 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TelyRx Holdings had revenue of CAD 112.80 million and -21.40 million in losses. Loss per share was -0.72.
| Revenue | 112.80M |
| Gross Profit | 64.38M |
| Operating Income | -19.71M |
| Pretax Income | -21.35M |
| Net Income | -21.40M |
| EBITDA | -18.99M |
| EBIT | -19.71M |
| Loss Per Share | -0.72 |
Balance Sheet
The company has 12.03 million in cash and 19.06 million in debt, with a net cash position of -7.02 million or -0.14 per share.
| Cash & Cash Equivalents | 12.03M |
| Total Debt | 19.06M |
| Net Cash | -7.02M |
| Net Cash Per Share | -0.14 |
| Equity (Book Value) | 12.96M |
| Book Value Per Share | 0.27 |
| Working Capital | 9.11M |
Cash Flow
In the last 12 months, operating cash flow was -11.93 million and capital expenditures -735,379, giving a free cash flow of -12.66 million.
| Operating Cash Flow | -11.93M |
| Capital Expenditures | -735,379 |
| Depreciation & Amortization | 716,191 |
| Net Borrowing | 3.88M |
| Free Cash Flow | -12.66M |
| FCF Per Share | -0.26 |
Margins
Gross margin is 57.08%, with operating and profit margins of -17.48% and -18.97%.
| Gross Margin | 57.08% |
| Operating Margin | -17.48% |
| Pretax Margin | -18.92% |
| Profit Margin | -18.97% |
| EBITDA Margin | -16.84% |
| EBIT Margin | -17.48% |
| FCF Margin | n/a |
Dividends & Yields
TelyRx Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -187.93% |
| Shareholder Yield | -187.93% |
| Earnings Yield | -31.23% |
| FCF Yield | -11.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on April 7, 2026. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | Apr 7, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |